drugset / Trial / NCT05294367

Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma

NCT05294367

Non-randomizedSequentialOpen-labelTreatment

Summary

This early phase I trial investigates the effect of dietary and topical magnesium replacement on magnesium blood levels in patients with lymphoma. Magnesium is an element in the body that is important to cell health. The body cannot make magnesium and it typically comes from the food we eat. In patients who are ill, magnesium is often replaced intravenously (IV) through a vein or by mouth. This study may help researchers find out if being on a magnesium rich diet and using a magnesium lotion on the skin helps to keep magnesium blood levels in an ideal range. This study also investigates side effects and quality of life when receiving different forms of magnesium.

Timeline

Start
2022-04-15
Primary completion
2027-04-01
Completion
2027-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject MAGNESIUM CHLORIDE ANHYDROUS Small molecule Topical

Indications